Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of SCOTUS tariff ruling on the pharmaceutical industry, news of Novo Nordisk’s weight loss drug failing to match Eli Lilly’s in trial, and more.
Dr. Scott Gottlieb: Tariffs are a very inefficient tool to reshore drug manufacturing
By superadmin
